Phio Pharmaceuticals Corp. (PHIO)
NASDAQ · Healthcare
Phio Pharmaceuticals Corp. Shareholder Equity 2012–2020
Phio Pharmaceuticals Corp. annual shareholder equity history from 2012 to 2020. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Phio Pharmaceuticals Corp. shareholder equity as of December 31, 2020: 13.0M, a 126.46% increase year-over-year.
- Phio Pharmaceuticals Corp. shareholder equity for 2020 were 13.0M, a 126.46% increase from 2019.
- Phio Pharmaceuticals Corp. shareholder equity for 2019 were 5.7M, a 57.67% decrease from 2018.
- Phio Pharmaceuticals Corp. shareholder equity for 2018 were 13.6M, a 640.75% increase from 2017.
- Phio Pharmaceuticals Corp. shareholder equity for 2017 were 1.8M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Phio Pharmaceuticals Corp. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2020 | $13 |
| 2019 | $6 |
| 2018 | $14 |
| 2017 | $2 |
| 2016 | $11 |
| 2015 | $9 |
| 2013 | $5 |
| 2012 | $-6 |
Phio Pharmaceuticals Corp. Shareholder Equity — FAQ
Phio Pharmaceuticals Corp. (PHIO) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PHIO's shareholder equity history?
The chart and table above show Phio Pharmaceuticals Corp.'s shareholder equity by year and by quarter, including the growth rate.